User profiles for "author:D Chen"

Daniel S Chen

- Verified email at engenuitylife.com - Cited by 42459

Di Chen

- Verified email at siat.ac.cn - Cited by 32566

Dehao Chen

- Verified email at google.com - Cited by 4803

[PDF][PDF] Oncology meets immunology: the cancer-immunity cycle

DS Chen, I Mellman - immunity, 2013 - cell.com
The genetic and cellular alterations that define cancer provide the immune system with the
means to generate T cell responses that recognize and eradicate cancer cells. However …

Elements of cancer immunity and the cancer–immune set point

DS Chen, I Mellman - Nature, 2017 - nature.com
Immunotherapy is proving to be an effective therapeutic approach in a variety of cancers. But
despite the clinical success of antibodies against the immune regulators CTLA4 and PD …

Bone morphogenetic proteins

DI Chen, M Zhao, GR Mundy - Growth factors, 2004 - Taylor & Francis
Bone morphogenetic proteins (BMPs) are multi-functional growth factors that belong to the
transforming growth factor β (TGFβ) superfamily. The roles of BMPs in embryonic …

Beyond the imitation game: Quantifying and extrapolating the capabilities of language models

…, D Perszyk, D Hernandez, D Chen… - arXiv preprint arXiv …, 2022 - arxiv.org
Language models demonstrate both quantitative improvement and new qualitative
capabilities with increasing scale. Despite their potentially transformative impact, these new …

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

RS Herbst, JC Soria, M Kowanetz, GD Fine, O Hamid… - Nature, 2014 - nature.com
The development of human cancer is a multistep process characterized by the accumulation
of genetic and epigenetic alterations that drive or reflect tumour progression. These changes …

[HTML][HTML] Compassionate use of remdesivir for patients with severe Covid-19

…, S Ahmed, J Bernett, D Chelliah, D Chen… - … England Journal of …, 2020 - Mass Medical Soc
Background Remdesivir, a nucleotide analogue prodrug that inhibits viral RNA
polymerases, has shown in vitro activity against SARS-CoV-2. Methods We provided …

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial

A Rittmeyer, F Barlesi, D Waterkamp, K Park… - The Lancet, 2017 - thelancet.com
Background Atezolizumab is a humanised antiprogrammed death-ligand 1 (PD-L1)
monoclonal antibody that inhibits PD-L1 and programmed death-1 (PD-1) and PD-L1 and …

Lamda: Language models for dialog applications

…, Y Huang, M Krikun, D Lepikhin, J Qin, D Chen… - arXiv preprint arXiv …, 2022 - arxiv.org
We present LaMDA: Language Models for Dialog Applications. LaMDA is a family of
Transformer-based neural language models specialized for dialog, which have up to 137B …

Asian emissions in 2006 for the NASA INTEX-B mission

…, IS Park, S Reddy, JS Fu, D Chen… - Atmospheric …, 2009 - acp.copernicus.org
A new inventory of air pollutant emissions in Asia in the year 2006 is developed to support
the Intercontinental Chemical Transport Experiment-Phase B (INTEX-B) funded by the …

Neuronal ensemble control of prosthetic devices by a human with tetraplegia

…, JA Mukand, M Saleh, AH Caplan, A Branner, D Chen… - Nature, 2006 - nature.com
Neuromotor prostheses (NMPs) aim to replace or restore lost motor functions in paralysed
humans by routeing movement-related signals from the brain, around damaged parts of the …